Hydrogenology
Hydrogenology editorial study record

Hydrogen coadministration slows the development of COPD-like lung disease in a cigarette smoke-induced rat model.

Liu X, Ma C, Wang X, Wang W, Li Z, Wang X, Wang P, Sun W, Xue B. · 2017.

PreclinicalInhaled H₂Published 2017
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled rat dose-comparison study

Research topic

Respiratory health

Administration classification

Inhaled H₂

Study result signal

Positive preclinical signal with non-linear dose findings.

Outcome type

Animal physiological, tissue and mechanistic outcomes.

Reported in the source

Methods at a glance

Population or model

Rats in a cigarette-smoke-induced COPD-like lung-disease model.

Sample

Animal groups and assay counts were checked in the full article.

Duration

Repeated exposure during development of the COPD-like model.

Intervention

Inhalation of 2%, 22% or 41.6% hydrogen during smoke exposure.

Hydrogen form

Inhaled molecular H₂ at three concentrations.

H₂ specification

2%, 22% and 41.6% H₂; absolute gas flows require the linked methods.

H₂ flow

No single separately verified H₂ flow is reported here.

O₂ delivered with H₂

Carrier-gas composition varies by arm; no Brown's-gas label is inferred.

Comparator

Smoke-exposed controls and multiple H₂ concentrations.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Lung function, pulmonary pressure, histology, inflammatory cells, cytokines, proteases and apoptosis markers.

Reported result

Hydrogen groups were reported to have better lung and cardiovascular measures and lower inflammatory or apoptotic markers, with some higher-concentration outcomes stronger than 2%.

Results-extraction completeness

The full article was checked for methods, intervention details, outcomes, positive and null findings, funding and conflicts. This record does not imply medical efficacy.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Animal model with unusually high gas concentrations, many outcomes and no basis for selecting a human dose.

Applies directly to

The reported smoke-exposed rat model only.

Preliminary appraisal framework

SYRCLE animal-study tool — preliminary

Preliminary risk-of-bias status

Some concerns

Appraisal rationale

Dose controls were present, but concealment, blinded assessment and multiplicity handling were not fully established.

Appraisal domains

Sequence generation checked where reported · Allocation concealment generally unclear · Personnel blinding generally unclear · Outcome-assessor blinding generally unclear · No prospectively registered analysis plan identified

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 28496315 · DOI: 10.2147/copd.s124547

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official PubMed Central full article and PubMed bibliographic record; source identity, methods, intervention, results, funding and conflicts checked 10 August 2026.

Record revision

2026-08-10